Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative nalbuphine PCA for acute orthopedic fracture pain
ChiCTR-OPh-17011866Phase 4Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nalbuphine in bone fracture (Fx) (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: Visual analogue scale pain score, Quality of sleep score and 2 more. Started Jul 2017; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
bone fracture (Fx)
Beyond the preview
Go deeper on ChiCTR-OPh-17011866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPh-17011866.